What does CUSIP 126638105 represent in this 13F holders report?

CUSIP 126638105 is the security identifier for CVRX - CVRx, Inc. - Common Stock, $0.01 par value used to aggregate holder disclosures.

How many institutions held CVRX - CVRx, Inc. - Common Stock, $0.01 par value in Q4 2024?

91 institutional investors reported CVRX - CVRx, Inc. - Common Stock, $0.01 par value for Q4 2024. Use the holders table for investor-level position and value details.

CVRx, Inc. - Common Stock, $0.01 par value (CVRX)

CUSIP: 126638105

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class: Equity / Common Stock, $0.01 par value
Total 13F shares: 15,154,273
Total 13F value: $192,128,165
Share change: +873,343
Put/Call ratio: 8.2%
SEC-reported price per share: $12.67
Number of holders: 91
Value change: +$11,666,171
Number of buys: 40
Number of sells: 40
Shares outstanding: 26,577,273

Security key

126638105

Report period

Q4 2024

Institutions

Top holders

CVRX full security history Ownership snapshot Full 13F holder table CVRx, Inc. SEC filings CVRx, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CVRX - CVRx, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Vensana Capital I GP, LLC

Disclosed value leader

JOHNSON & JOHNSON

Comparable rows

15/15

Latest evidence

31 Dec 2024

13D/G 13F Lead comparable stake: 7.2% 13D/G row: Vensana Capital I GP, LLC Showing 1-6 of 15 holder rows.

Quick read

Vensana Capital I GP, LLC leads the comparable SEC ownership view at 7.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vensana Capital I GP, LLC's linked filing trail.

Comparable ownership Top 5

Vensana Capital I GP, LLC 7.2%

JOHNSON & JOHNSON 15%

NEA Management Company, LLC 8.9%

BlackRock, Inc. 3.4%

VANGUARD GROUP INC 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Vensana Capital I GP, LLC	13D/G Kirk Nielsen 13D/G	7.2%	$11,849,740 1,760,734 shares	$0	31 Dec 2024
JOHNSON & JOHNSON	13F Company 13F	15%	$36,151,218 4,103,430 shares	—	30 Sep 2024
NEA Management Company, LLC	13F Company 13F	8.9%	$20,884,475 2,370,542 shares	—	30 Sep 2024
BlackRock, Inc.	13F Company 13F	3.4%	$8,012,017 909,423 shares	—	30 Sep 2024
VANGUARD GROUP INC	13F Company 13F	3.1%	$7,261,995 824,290 shares	—	30 Sep 2024
Parkman Healthcare Partners LLC	13F Company 13F	2.6%	$6,016,323 682,897 shares	—	30 Sep 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

15,154,273

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

Q4 2024 holders

Holder diff

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 value	Q4 2024 value	Value change	Value Chg %